Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

In the univariate model, in descending order of OR value, the factors associated with LVH included diabetes mellitus, systolic blood pressure, CVC, diastolic blood pressure, age, 24-hour urine volume (residual urine volume), dialysis age, hemoglobin, vitamin D, inorganic phosphorus, activity and light, hemodiafiltration, and calcium carbonate (P = .001, 0.000, 0.000, 0.001, 0.000, 0.035, 0.036, 0.002, 0.013, 0.013, 0.004, 0.002, and 0.001, respectively).

Source: 3.3. Analysis of factors correlated with LVH. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Cohort study.

Cohort study

Examines exposures and outcomes over time within a defined group.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Left ventricular hypertrophy and cardiac valve calcification and their impacts on survival in maintenance hemodialysis patients: A retrospective cohort study

Source: Article title.

All patients were given high flux dialyzer (ultrafiltration coefficient 44 to 49 mL/h/mm Hg), bicarbonate dialysis at dialysate flow of 500 ml/min and blood flow of 200 to 280 mL/min.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Left ventricular hypertrophy and cardiac valve calcification and their impacts on survival in maintenance hemodialysis patients: A retrospective cohort study

Cohort study · Medicine · 2025

Original publication title

Left ventricular hypertrophy and cardiac valve calcification and their impacts on survival in maintenance hemodialysis patients: A retrospective cohort study

Xiaochun Wu; Zhiping Sun; Gang Yao; Fuhua Zhou

Copyright © 2025 the Author(s). Published by Wolters Kluwer Health, Inc.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

At a glance

What does the authors’ abstract report?

The purpose of this article was to study the distribution of left ventricular hypertrophy (LVH) and cardiac valve calcification (CVC), relevant factors, and the relationship of LVH and CVC with survival in maintenance hemodialysis (MHD) patients. A total of 281 MHD patients were included in this retrospective and follow-up study. Echocardiography measurements were performed to evaluate the left ventricular structure and cardiac valve. Left ventricular mass (LVM), LVM index, relative wall thickness, and prevalence of LVH and CVC were calculated.

Factors related to LVH and CVC and patients’ death risk were analyzed. The primary outcome was death. The prevalence of LVH in this study was 50.53% (142 patients). Concentric hypertrophy, concentric remodeling, and eccentric hypertrophy were found in 39.86%, 25.98%, and 10.68% of patients, respectively. Factors associated with LVH included systolic pressure, CVC, hemoglobin, and calcium carbonate in a multivariate logistic regression model (all P <.01). The log-rank χ2, which were 10.957, 12.668, 10.181, and 8.474 at 6, 12, 18, and 24 months follow-up, respectively, in the Kaplan: Meier model demonstrated the lower survival rates in patients with LVH than in those without (all P <.01).

The prevalence of CVC was 60.14% (169 patients). Aortic valve calcification, mitral valve calcification, or both were found in 54.09%, 33.10%, and 27.05% of patients, respectively. In a multivariate logistic regression model, the factors associated with CVC were coronary heart disease, LVH, calcium, age, dialysis age, and diastolic pressure (P <.05). In COX proportional hazard model, LVH resulted as an independent risk factor to all-cause death; the adjusted HR was 11.045, 4.382, 3.075, and 2.586 at 6, 12, 18, and 24 months follow-up, respectively (all P <.05).

In MHD patients, LVH and CVC were highly prevalent, and LVH resulted as an independent risk factor for all-cause death.

Authors’ abstract

The purpose of this article was to study the distribution of left ventricular hypertrophy (LVH) and cardiac valve calcification (CVC), relevant factors, and the relationship of LVH and CVC with survival in maintenance hemodialysis (MHD) patients. A total of 281 MHD patients were included in this retrospective and follow-up study. Echocardiography measurements were performed to evaluate the left ventricular structure and cardiac valve. Left ventricular mass (LVM), LVM index, relative wall thickness, and prevalence of LVH and CVC were calculated.

Factors related to LVH and CVC and patients’ death risk were analyzed. The primary outcome was death. The prevalence of LVH in this study was 50.53% (142 patients). Concentric hypertrophy, concentric remodeling, and eccentric hypertrophy were found in 39.86%, 25.98%, and 10.68% of patients, respectively. Factors associated with LVH included systolic pressure, CVC, hemoglobin, and calcium carbonate in a multivariate logistic regression model (all P <.01). The log-rank χ2, which were 10.957, 12.668, 10.181, and 8.474 at 6, 12, 18, and 24 months follow-up, respectively, in the Kaplan: Meier model demonstrated the lower survival rates in patients with LVH than in those without (all P <.01).

The prevalence of CVC was 60.14% (169 patients). Aortic valve calcification, mitral valve calcification, or both were found in 54.09%, 33.10%, and 27.05% of patients, respectively. In a multivariate logistic regression model, the factors associated with CVC were coronary heart disease, LVH, calcium, age, dialysis age, and diastolic pressure (P <.05). In COX proportional hazard model, LVH resulted as an independent risk factor to all-cause death; the adjusted HR was 11.045, 4.382, 3.075, and 2.586 at 6, 12, 18, and 24 months follow-up, respectively (all P <.05).

In MHD patients, LVH and CVC were highly prevalent, and LVH resulted as an independent risk factor for all-cause death.

Publication and source details

Original title: Left ventricular hypertrophy and cardiac valve calcification and their impacts on survival in maintenance hemodialysis patients: A retrospective cohort study

Xiaochun Wu; Zhiping Sun; Gang Yao; Fuhua Zhou

Medicine · 2025

* Correspondence: Fuhua Zhou, Department of Nephrology, The Second Affiliated Hospital of Nanjing Medical University, Nanjing 210011, Jiangsu Province, China (e-mail: zhoufuhua0304@163.com).Copyright © 2025 the Author(s). Published by Wolters Kluwer Health, Inc.2025https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T03:08:43.369316+00:00

DOI: 10.1097/md.0000000000044181 · PMC12419373